Page last updated: 2024-08-26

hydroxyflutamide and promegestone

hydroxyflutamide has been researched along with promegestone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, DT; Chandrasekhar, Y1
Dauvois, S; Dumont, M; Haagensen, DE; Labrie, F; Simard, J1
Lumbroso, S; Moras, D; Nicolas, JC; Poujol, N; Sultan, C; Tahiri, B; Wurtz, JM1

Other Studies

3 other study(ies) available for hydroxyflutamide and promegestone

ArticleYear
Regulation of uterine progesterone receptors by the nonsteroidal anti-androgen hydroxyflutamide.
    Biology of reproduction, 1991, Volume: 45, Issue:1

    Topics: Androgen Antagonists; Animals; Dose-Response Relationship, Drug; Estradiol; Female; Flutamide; Organ Size; Promegestone; Rats; Rats, Inbred Strains; Receptors, Progesterone; Tritium; Uterus

1991
Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
    Molecular and cellular endocrinology, 1990, Oct-22, Volume: 73, Issue:2-3

    Topics: Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carrier Proteins; Cell Division; Drug Interactions; Estradiol; Flutamide; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Membrane Transport Proteins; Mifepristone; Neoplasm Proteins; Promegestone; Tumor Cells, Cultured

1990
Specific recognition of androgens by their nuclear receptor. A structure-function study.
    The Journal of biological chemistry, 2000, Aug-04, Volume: 275, Issue:31

    Topics: Amino Acid Sequence; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Binding Sites; Computer Simulation; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Ligands; Metribolone; Models, Molecular; Molecular Sequence Data; Nitriles; Progesterone; Promegestone; Receptors, Androgen; Sequence Alignment; Tosyl Compounds; Transcriptional Activation

2000